智通财经APP讯，欧科亿(688308.SH)发布公告，因股东自身资金需求，公司股东袁美和拟通过集中竞 价或大宗交易方式减持公司股份不超过300万股，即不超过公司目前总股本的1.89%。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 减持主体及持股情况 公告显示，减持主体袁美和为株洲欧科亿控股股东、实际控制人及一致行动人，同时也是直接持股5% 以上股东。截至公告披露日，袁美和持有公司股份2717.0076万股，占公司总股本的17.11%。其持有的 股份来源为首次公开发行前股份（含上市后资本公积金转增股本取得的股份）及通过非交易过户取得股 份，均为无限售条件流通股。 此外，袁美和存在一致行动人谭文清，二者通过签署《一致行动人协议》形成一致行动关系。谭文清当 前持有公司1434.6360万股股份，占总股本的9.01%。 减持计划具体内容 株洲欧科亿数控精密刀具股份有限公司（以下简称"株洲欧科亿"）于2025年12月24日发布股东减持股份 计划公告，公司控股股东、实际控制人之一袁美和因自身资金需求，拟在未来3个月内通过集中竞价或 大宗交易方式减持公司股份不超过300万股，占公司当前总股本的1.89%。 减持时间区间 本次减持将于公告披露之日起15个交易日后的3个月内进行，具体时间为2026年1月19日至2026年4月18 日。其中，通过集中竞价交易方式减持的，在任意连续90日内减持股份总数不超过 ...

Group 1 - Shareholder of Okoyi plans to reduce holdings by up to 1.89% of the company's shares, amounting to a maximum of 3 million shares due to personal funding needs [1] - Tianchuang Fashion is planning a change in control, leading to continued suspension of its stock trading, expected to last no more than 3 trading days [2] - China Electric Power Construction Company reported a new contract amount of 10,317.55 billion yuan for the first 11 months of 2025, a year-on-year decrease of 1.65% [3] Group 2 - Pilin Bio's wholly-owned subsidiary received approval for a clinical trial of a drug, indicating progress in its product development [4] - Yihong Medical obtained two medical device registration certificates for diagnostic kits, enhancing its product portfolio [5] - Aohong Electronics plans to use up to 450 million yuan of idle fundraising for cash management, targeting safe and liquid financial products [6] Group 3 - China Electric Power Construction signed a contract worth approximately 6.626 billion yuan for a natural gas booster station project in Turkey, with a construction period of about 55 months [7] - Baosheng Co. won a bid for a power cable project in Singapore, valued at around 1.2 billion yuan, marking the largest overseas order in its history [8] - *ST Xinyan's stock will resume trading on December 24, 2025, following a capital increase plan that will raise its total share capital to 3.29 billion shares [9] Group 4 - Ningbo Construction's subsidiary signed a construction contract worth 428 million yuan for an engineering project with a duration of 990 days [11] - Lianhuan Pharmaceutical's subsidiary received approval for a drug that passed the consistency evaluation for generic drugs, enhancing its market competitiveness [12] - Zhongjie Automotive received a project designation for a new electric air conditioning compressor, with expected sales of approximately 29.86 million USD over its lifecycle [13] Group 5 - Biopharmaceuticals' major shareholder plans to increase holdings by 50 million to 100 million yuan, indicating confidence in the company's future [14] - Haizheng Pharmaceutical's subsidiary received approval for a veterinary drug product, expanding its product offerings in the animal health sector [15] - *ST Songfa's subsidiary signed contracts for the construction of 8 vessels, with a total contract value between 200 million to 400 million USD [16] Group 6 - Shandong Pharmaceutical Glass announced the resignation of its chairman due to age reasons, indicating a potential leadership transition [17] - Xinno Wei's subsidiary received approval for a clinical trial of a monoclonal antibody drug, indicating advancements in its drug development pipeline [18] - Ningbo Huaxiang's subsidiary secured an order for robot joints, expected to positively impact future business performance [19][20] Group 7 - China Resources Double Crane's subsidiary received approval for a clinical trial of a drug aimed at treating a genetic eye disease, reflecting ongoing R&D efforts [21] - Huaxin Technology's shareholders set a transfer price of 56.69 yuan per share for a block of shares, indicating active shareholder engagement [22] - Xinhua Net announced the resignation of its president due to job relocation, suggesting potential changes in management [23] Group 8 - Taiji Group plans to transfer a 40% stake in a subsidiary to focus on its core pharmaceutical business, enhancing operational efficiency [24] - Huaxin Construction's shareholder plans to increase holdings by 200 million to 400 million yuan, reflecting confidence in the company's prospects [25] - Dongjie Intelligent is planning to issue shares and cash for asset acquisition, with stock trading suspended until further notice [26] Group 9 - Wanrun New Energy was designated as a delivery warehouse for lithium carbonate futures, indicating its strategic position in the market [27] - Prolo Pharmaceutical's subsidiary received a drug registration certificate for an influenza treatment, expanding its product range [28] - Saiwu Technology invested 5 million yuan in a private equity fund focused on smart vehicles and energy innovation, indicating strategic investment in growth sectors [29] Group 10 - Bohui Innovation's subsidiary received approval for a clinical trial of an immunoglobulin drug, indicating progress in its product development [30] - Bohui Innovation's subsidiary also received a drug registration certificate for a coagulation factor product, enhancing its therapeutic offerings [31] - Hanghua Co. plans to allocate 146 million yuan of surplus fundraising for a new green printing materials project, reflecting a commitment to sustainability [32] Group 11 - Nova Star Cloud obtained a loan commitment letter from a bank for a share repurchase plan, indicating financial support for its capital management strategy [33] - Jimin Health established a joint venture for technology innovation, indicating a strategic move to enhance its technological capabilities [34] - Huili Pharmaceutical received a drug registration certificate for a medication used in treating digestive ulcers, expanding its product portfolio [35]

格隆汇12月23日丨欧科亿(688308.SH)公布，因股东自身资金需求，公司股东袁美和先生拟通过集中竞 价或大宗交易方式减持公司股份不超过300万股，即不超过公司目前总股本的1.89%。本次减持将于本 公告披露之日起15个交易日后的3个月内进行，通过集中竞价交易方式减持的，在任意连续90日内，减 持股份的总数不超过公司股份总数的1%；通过大宗交易方式减持的，在任意连续90日内，减持股份的 总数不超过公司股份总数的2%。 ...

人民财讯12月23日电，欧科亿(688308)12月23日公告，股东袁美和持有公司17.11%的股份，拟通过集中 竞价或大宗交易方式，减持公司股份不超过300万股，即不超过公司目前总股本的1.89%。 ...

证券代码：688308 证券简称：欧科亿 公告编号：2025-041 株洲欧科亿数控精密刀具股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： | | 股东名称 | 持有数量（股） | | 持有比例 | 一致行动关系形成原因 | | --- | --- | --- | --- | --- | --- | | 第一组 | | | | | 袁美和先生与谭文清先 | | | 谭文清 | | 14,346,360 | 9.01% | 生签署了《一致行动人协 | | | | | | | 议》 | | | 合计 | | 14,346,360 | 9.01% | — | 股东持股的基本情况 截至本公告披露之日，株洲欧科亿数控精密刀具股份有限公司（以下简称"公 司"）股东袁美和先生持有公司 27,170,076 股股份，占公司总股本的 17.11%。 上述股份为公司首次公开发行前股份（含上市后资本公积金转增股本取得的股份） 及通过非交易过户取得股份，均为无限售条件流通股。 减持计 ...

欧科亿公告，股东袁美和因自身资金需求，拟通过集中竞价或大宗交易方式减持公司股份不超过300万 股，即不超过公司目前总股本的1.89%。本次减持将于本公告披露之日起15个交易日后的3个月内进 行。 ...

欧科亿公告，截至披露日，股东袁美和持有公司2717.01万股，占总股本17.11%；因自身资金需求，拟 自2026年1月19日～2026年4月18日通过集中竞价或大宗交易方式合计减持不超过300万股，不超公司总 股本1.89%。其中，集中竞价减持不超157万股，且任意连续90日内不超公司股份总数1%；大宗交易减 持不超143万股，且任意连续90日内不超公司股份总数2%。拟减持股份均为首次公开发行前股份及通过 非交易过户取得的无限售条件流通股。 ...

格隆汇12月23日｜有投资者在互动平台向欧科亿提问：公司三季度末库存的钨材料以及在产品大约有多 少？有没有3个亿？12月钨价环比三季度大幅增长了70%左右，公司库存的钨材料是否大约升值了2个 亿？刀具价格如果涨幅没有那么大，是否可以考虑卖出部分钨材料以获取不菲的收益？ 欧科亿回复 称，公司三季度末库存的钨材料及在产品约3.5亿左右，目前，刀具产品价格大幅上涨，公司将聚焦更 多结构升级产品，同时利用自身原料库存优势，进一步提升公司盈利能力。 ...

格隆汇12月23日丨欧科亿(688308.SH)在投资者互动平台表示，公司三季度末库存的钨材料及在产品约 3.5亿左右，目前，刀具产品价格大幅上涨，公司将聚焦更多结构升级产品，同时利用自身原料库存优 势，进一步提升公司盈利能力。 ...